WELCOME OFFER — 10% OFF YOUR FIRST ORDER · CODE LAUNCH10 · GET IT BY EMAIL

Ingredient knowledge · Probiotics

Bifidobacterium longum

The lifelong coloniser — a live culture named to subspecies

All articles checked for accuracy against the GB NHC Register and all sources have citations with verified links to their relevant studies.

A common gut bacterium across the life course, Bifidobacterium longum is often the dominant bifidobacterium in later life and includes the organism historically labelled B. infantis. WellsparQ lists it as a named live culture when present in blends.

This article explains what Bifidobacterium longum is, why taxonomic detail matters, what distinguishes the main subspecies, how research maps to strains, and how WellsparQ declares and measures the culture in products. It emphasises regulatory limits on claims and the distinction between species-level description and strain-specific research.

Ingredient Snapshot

Bifidobacterium longum ingredient
What it is
A species of bifidobacteria commonly found across the human lifespan.
Where from
Bifidobacterium longum (includes subspecies longum, infantis, suis)
Known for
A prevalent gut-colonising bacterium with strains studied as named live cultures.

If B. bifidum is the founder of the genus and B. infantis is the infant specialist, Bifidobacterium longum is the one that tends to stay. It is among the most prevalent bifidobacteria across the whole human lifespan — present in infants, common in adults, and often the dominant Bifidobacterium in older age ¹². The species name "longum" simply means "long", after the elongated rod shape. On a WellsparQ card it is one named live culture in a blend, declared and counted. This page focuses on what is specific to B. longum — including a taxonomy detail that ties it to the infantis article.

One species, three subspecies

B. longum is not a single uniform thing. In 2008 Mattarelli and colleagues classified it into three subspecies: B. longum subsp. longum, B. longum subsp. infantis and B. longum subsp. suis ³. This is the same reclassification that renamed the old "B. infantis" — so the organism many labels still call B. infantis is, correctly, a subspecies of B. longum ³. When a product lists both "B. longum" and "B. infantis" as separate cultures, it is really listing two subspecies of the same species — worth knowing, and reflected in WellsparQ's honesty about what is in the jar.

SubspeciesTypical nicheNote
B. longum subsp. longumInfant, adult and elderly gut; often dominant in later life ¹²The "adult-associated", plant-glycan metaboliser
B. longum subsp. infantisBreastfed-infant gutThe milk/HMO specialist (see the B. infantis article) ³
B. longum subsp. suisPig gutNot a human-supplement subspecies ³

Unless a product specifies the subspecies, "B. longum" on a label usually refers to subsp. longum, the lifelong human coloniser.

What sets subsp. longum apart

The longum subspecies is a generalist of the adult diet. Where subsp. infantis is built around milk sugars, subsp. longum carries a broad set of enzymes for plant-derived carbohydrates — the arabinoxylans, arabinans and other fibres common in an adult diet that the human body cannot digest itself ⁴. This dietary flexibility is thought to be one reason it colonises so widely and persists across the lifespan, and why it is frequently the main bifidobacterium found in older adults ¹². Again, this is a description of the organism's biology — how and where it lives — not a statement of what a supplement does.

What the named-strain research shows — and its limits

Effects belong to strains, not to species. The most-studied B. longum strain in recent research is 1714, examined not for the gut but for stress and cognition. Allen and colleagues (2016) gave 22 healthy volunteers the strain in a within-subject, placebo-controlled design and reported changes in cortisol response and self-reported stress during an acute stress task, alongside subtle differences in memory and brain electrical activity ⁵. A later randomised, double-blind, placebo-controlled trial reported effects of the same strain on sleep quality and aspects of well-being in healthy adults ⁶.

Three honest caveats. First, these findings attach to strain 1714 specifically, not to B. longum as a species, and not to the culture in any particular product. Second, sample sizes in this field are often small and results are early. Third, the NHS notes that evidence for live-culture products overall is limited, and that retail products may differ from graded research material ⁷. Context, not a product claim.

How a live culture is measured

Live cultures are counted, not merely weighed. The unit is the colony-forming unit (CFU) — viable cells able to grow into colonies. A milligram figure is the mass of freeze-dried culture plus carrier; a CFU figure is the verified live count at manufacture. Viable counts fall over time, so the number is a shelf-life property, and storage as directed protects it.

In WellsparQ's GutBiome 20, B. longum is described on the factsheet card as "one of three Bifidobacterium species in the blend". It sits alongside the other named cultures — including the infantis subspecies — as a declared component of a multi-strain formula, not a solo act.

In the WellsparQ rangeDeclared asRole
GutBiome 20Bifidobacterium longum (i.e. subsp. longum)One of three Bifidobacterium species in the blend

The blend is a bacterial culture preparation; suitability for vegan, kosher or halal diets follows the specific product record.

Suitability and sensible use

B. longum is a normal, lifelong member of the human gut with a long record of use in foods and supplements. As with any live-culture product, anyone pregnant, breastfeeding, seriously unwell or immunocompromised should speak to a GP or pharmacist first ⁷. Keep to the stated directions and storage.

In short

B. longum subsp. longum is the lifelong human coloniser — a fibre-adapted generalist that persists from infancy into old age, and the parent species of the organism many still call B. infantis. The research most cited for it, strain 1714 in stress and sleep, belongs to that strain and remains early. WellsparQ names the species, counts the culture, and lets the evidence stand as evidence.

References

  1. Alessandri G, van Sinderen D, Ventura M. Bifidobacteria: insights into the biology of a key microbial group of early life gut microbiota. Microbiome Research Reports, 2023. PMC10688781 (prevalence across lifespan; dominance in older adults). ↩ Back to text
  2. Odamaki T, et al. Genomic diversity and distribution of Bifidobacterium longum subsp. longum across the human lifespan. (open-access) PMC5758520 (lifespan distribution). ↩ Back to text
  3. Mattarelli P, Bonaparte C, Pot B, Biavati B. Proposal to reclassify the three biotypes of Bifidobacterium longum as three subspecies. International Journal of Systematic and Evolutionary Microbiology, 2008;58:767–772. PMID 18398167. ↩ Back to text
  4. Arzamasov AA / Rodionova IA, et al. Plant glycan metabolism by bifidobacteria (review of plant-carbohydrate utilisation in B. longum subsp. longum). PMC7889515. ↩ Back to text
  5. Allen AP, et al. Bifidobacterium longum 1714 as a translational psychobiotic: modulation of stress, electrophysiology and neurocognition in healthy volunteers. Translational Psychiatry, 2016;6:e939. PMC5314114. ↩ Back to text
  6. Patterson E, et al. Bifidobacterium longum 1714 improves sleep quality and aspects of well-being in healthy adults: a randomized, double-blind, placebo-controlled clinical trial. Scientific Reports, 2024;14. (Nature Portfolio, s41598-024-53810-w). PMID 38355674 ↩ Back to text
  7. NHS. Probiotics — nhs.uk/tests-and-treatments/probiotics (limited evidence; product-quality caveat). ↩ Back to text
  8. Food Safety Authority of Ireland. Probiotic Health Claims — fsai.ie ("probiotic" as unauthorised health claim, Reg. (EC) 1924/2006). ↩ Back to text
  9. EFSA. Health claims topic page and the EU Register of nutrition and health claims — efsa.europa.eu / ec.europa.eu. ↩ Back to text
General information only — not medical advice. Food supplements should not be used as a substitute for a varied diet and a healthy lifestyle. Do not exceed the stated recommended daily dose. Keep out of reach of young children. If you are pregnant, breastfeeding, or taking medication, speak to your GP or pharmacist before starting a new supplement.
Shopping Basket